Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center
About this trial
To observe the outcomes of nsPFA therapy to treat benign thyroid nodules.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Scheduled to undergo ultrasound guided nsPFA as standard of care
Age 18 to 80 years.
Capable of providing independent consent.
Benign FNA X 2 or
Disqualifiers
Age <18
Patients considered unsuitable for nsPFA by the treating physician
Trial population
MD Anderson Cancer Center
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Questionnaire
Other interventionpatient-reported outcomes questionnaire
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Quality-of-life Questionnaire
Time frame
Through study completion; an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov